Healthy Adult Volunteers Clinical Trial
Official title:
An Open-label, Randomized, Fasted, Single-dose, Oral Administration, 2-sequence, 2-period Crossover Study to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Adult Volunteers
This Clinical Trial is an open, randomized, fasted, single-dose, oral administration 2-sequence, 2-period crossover study to assess bioequivalence of lazertinib between two formulations in healthy adult volunteers. The subjects administer 240mg of lazertinib of different formulations on the fasted status on each period and have a wash-out period for 14-21 days between the first and second period.
This clinical trial will be conducted in healthy male volunteers at Seoul National University Hospital (SNUH) Clinical Trial Center. It is expected to take approximately 32 days from the first dosing of Investigational Product until the final follow-up visit. Subjects will be hospitalized twice for 4 nights and 5 days with 7-14 days of wash-out period, and one visit will be needed for safety evaluation between 14-17 days from the last dosing of the Investigational Product. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06034899 -
A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants
|
Phase 1 | |
Completed |
NCT03748758 -
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
|
Phase 1 | |
Recruiting |
NCT06008652 -
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
|
Phase 1 | |
Terminated |
NCT02079480 -
Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01657838 -
Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT01651325 -
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT01354379 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer
|
Phase 1 | |
Completed |
NCT01129466 -
Effects of 2 Different Broccoli Sprout Containing Supplements on Nasal Cells in Healthy Volunteers
|
N/A | |
Completed |
NCT04856969 -
Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT01333462 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008
|
Phase 1 | |
Completed |
NCT02942771 -
A MAD Study of TT301/MW189 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02822898 -
Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults
|
Phase 4 | |
Completed |
NCT05017987 -
Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012
|
Phase 1 | |
Not yet recruiting |
NCT05757596 -
Study of VSA001 Injection in Chinese Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT05074368 -
Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination
|
N/A | |
Completed |
NCT01672242 -
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
|
N/A | |
Completed |
NCT03878693 -
4-methylpyrazole and Acetaminophen Metabolism
|
Early Phase 1 | |
Completed |
NCT04204772 -
A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
|
Early Phase 1 | |
Completed |
NCT05154461 -
Intestinal Ketone Bodies Interfere With the Glycemic Control
|
N/A | |
Active, not recruiting |
NCT02058472 -
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
|
Phase 1 |